Literature DB >> 30878290

Pain-Induced Negative Affect Is Mediated via Recruitment of The Nucleus Accumbens Kappa Opioid System.

Nicolas Massaly1, Bryan A Copits1, Adrianne R Wilson-Poe1, Lucia Hipólito2, Tamara Markovic1, Hye Jean Yoon1, Shiwei Liu3, Marie C Walicki4, Dionnet L Bhatti1, Sunil Sirohi5, Amanda Klaas6, Brendan M Walker5, Rachael Neve7, Catherine M Cahill3, Kooresh I Shoghi8, Robert W Gereau9, Jordan G McCall4, Ream Al-Hasani10, Michael R Bruchas11, Jose A Morón12.   

Abstract

Negative affective states affect quality of life for patients suffering from pain. These maladaptive emotional states can lead to involuntary opioid overdose and many neuropsychiatric comorbidities. Uncovering the mechanisms responsible for pain-induced negative affect is critical in addressing these comorbid outcomes. The nucleus accumbens (NAc) shell, which integrates the aversive and rewarding valence of stimuli, exhibits plastic adaptations in the presence of pain. In discrete regions of the NAc, activation of the kappa opioid receptor (KOR) decreases the reinforcing properties of rewards and induces aversive behaviors. Using complementary techniques, we report that in vivo recruitment of NAc shell dynorphin neurons, acting through KOR, is necessary and sufficient to drive pain-induced negative affect. Taken together, our results provide evidence that pain-induced adaptations in the kappa opioid system within the NAc shell represent a functional target for therapeutic intervention that could circumvent pain-induced affective disorders. VIDEO ABSTRACT.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30878290      PMCID: PMC6509001          DOI: 10.1016/j.neuron.2019.02.029

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  43 in total

1.  Nucleus Accumbens Subnuclei Regulate Motivated Behavior via Direct Inhibition and Disinhibition of VTA Dopamine Subpopulations.

Authors:  Hongbin Yang; Johannes W de Jong; YeEun Tak; James Peck; Helen S Bateup; Stephan Lammel
Journal:  Neuron       Date:  2018-01-04       Impact factor: 17.173

2.  A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor.

Authors:  W Jeffrey Elias; Nir Lipsman; William G Ondo; Pejman Ghanouni; Young G Kim; Wonhee Lee; Michael Schwartz; Kullervo Hynynen; Andres M Lozano; Binit B Shah; Diane Huss; Robert F Dallapiazza; Ryder Gwinn; Jennifer Witt; Susie Ro; Howard M Eisenberg; Paul S Fishman; Dheeraj Gandhi; Casey H Halpern; Rosalind Chuang; Kim Butts Pauly; Travis S Tierney; Michael T Hayes; G Rees Cosgrove; Toshio Yamaguchi; Keiichi Abe; Takaomi Taira; Jin W Chang
Journal:  N Engl J Med       Date:  2016-08-25       Impact factor: 91.245

Review 3.  Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment.

Authors:  Nicole A Crowley; Thomas L Kash
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-01-12       Impact factor: 5.067

4.  Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state.

Authors:  Minoru Narita; Yayoi Kishimoto; Yuya Ise; Yoshinori Yajima; Kaoru Misawa; Tsutomu Suzuki
Journal:  Neuropsychopharmacology       Date:  2005-01       Impact factor: 7.853

5.  The one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors.

Authors:  Jessica L Kissler; Sunil Sirohi; Daniel J Reis; Heiko T Jansen; Raymond M Quock; Daniel G Smith; Brendan M Walker
Journal:  Biol Psychiatry       Date:  2013-04-21       Impact factor: 13.382

6.  Chronic pain patients are impaired on an emotional decision-making task.

Authors:  A Vania Apkarian; Yamaya Sosa; Beth R Krauss; P Sebastian Thomas; Bruce E Fredrickson; Robert E Levy; R Norman Harden; Dante R Chialvo
Journal:  Pain       Date:  2004-03       Impact factor: 6.961

Review 7.  The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.

Authors:  M R Bruchas; B B Land; C Chavkin
Journal:  Brain Res       Date:  2009-08-28       Impact factor: 3.252

8.  Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.

Authors:  Benjamin B Land; Michael R Bruchas; Selena Schattauer; William J Giardino; Megumi Aita; Daniel Messinger; Thomas S Hnasko; Richard D Palmiter; Charles Chavkin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-28       Impact factor: 11.205

9.  Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.

Authors:  Elyssa B Margolis; Gregory O Hjelmstad; Antonello Bonci; Howard L Fields
Journal:  J Neurosci       Date:  2003-11-05       Impact factor: 6.167

10.  Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor.

Authors:  Tao Che; Susruta Majumdar; Saheem A Zaidi; Pauline Ondachi; John D McCorvy; Sheng Wang; Philip D Mosier; Rajendra Uprety; Eyal Vardy; Brian E Krumm; Gye Won Han; Ming-Yue Lee; Els Pardon; Jan Steyaert; Xi-Ping Huang; Ryan T Strachan; Alexandra R Tribo; Gavril W Pasternak; F Ivy Carroll; Raymond C Stevens; Vadim Cherezov; Vsevolod Katritch; Daniel Wacker; Bryan L Roth
Journal:  Cell       Date:  2018-01-04       Impact factor: 41.582

View more
  53 in total

1.  Reduced nucleus accumbens enkephalins underlie vulnerability to social defeat stress.

Authors:  Hyungwoo Nam; Ramesh Chandra; T Chase Francis; Caroline Dias; Joseph F Cheer; Mary Kay Lobo
Journal:  Neuropsychopharmacology       Date:  2019-05-27       Impact factor: 7.853

Review 2.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

Review 3.  Endogenous Opioids at the Intersection of Opioid Addiction, Pain, and Depression: The Search for a Precision Medicine Approach.

Authors:  Michael A Emery; Huda Akil
Journal:  Annu Rev Neurosci       Date:  2020-02-28       Impact factor: 12.449

4.  Effects of repeated treatment with monoamine-transporter-inhibitor antidepressants on pain-related depression of intracranial self-stimulation in rats.

Authors:  L P Legakis; L Karim-Nejad; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2020-05-08       Impact factor: 4.530

5.  Differential mitochondrial morphology in ventral striatal projection neuron subtypes.

Authors:  Ramesh Chandra; Cali A Calarco; Mary Kay Lobo
Journal:  J Neurosci Res       Date:  2019-08-07       Impact factor: 4.164

Review 6.  Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion.

Authors:  Elyssa B Margolis; Anushree N Karkhanis
Journal:  Neurochem Int       Date:  2019-07-10       Impact factor: 3.921

7.  Pleiotropic Effects of Kappa Opioid Receptor-Related Ligands in Non-human Primates.

Authors:  Mei-Chuan Ko; Stephen M Husbands
Journal:  Handb Exp Pharmacol       Date:  2020-12-04

Review 8.  Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects.

Authors:  Kelly F Paton; Diana V Atigari; Sophia Kaska; Thomas Prisinzano; Bronwyn M Kivell
Journal:  J Pharmacol Exp Ther       Date:  2020-09-10       Impact factor: 4.030

Review 9.  Amygdala, neuropeptides, and chronic pain-related affective behaviors.

Authors:  Volker Neugebauer; Mariacristina Mazzitelli; Bryce Cragg; Guangchen Ji; Edita Navratilova; Frank Porreca
Journal:  Neuropharmacology       Date:  2020-03-15       Impact factor: 5.250

Review 10.  From Pleasure to Pain, and Back Again: The Intricate Relationship Between Alcohol and Nociception.

Authors:  Meridith T Robins; Mary M Heinricher; Andrey E Ryabinin
Journal:  Alcohol Alcohol       Date:  2019-12-01       Impact factor: 2.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.